Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kempharm Inc

(NASDAQ: KMPH)
Add to Portfolio
+0.04 (+7.75%)
as of Nov 14, 2019

KemPharm Reports Third Quarter 2019 Results

GlobeNewswire via COMTEX - Thu Nov 14, 04:55PM EST
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, November 14, 2019, at 5:30 p.m. ET(full story)
KMPH: 0.51 (+0.04)

KemPharm to Report Third Quarter 2019 Results

GlobeNewswire via COMTEX - Tue Nov 12, 08:30AM EST
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for(full story)
KMPH: 0.51 (+0.04)

KemPharm Reports APADAZ(R) Will be Available

GlobeNewswire via COMTEX - Thu Oct 31, 08:30AM EDT
KVK-Tech is Initially Stocking Selected Regions Based on Formulary Access(full story)
KMPH: 0.51 (+0.04)

KemPharm Presents Study Highlighting Patient-Friendly

GlobeNewswire via COMTEX - Tue Oct 22, 04:15PM EDT
Data Demonstrate that KP415 Can Be Administered without Regard to Food; Can Be Mixed into Foods or Drink(full story)
PTCI: 0.5500 (+0.1500), KMPH: 0.51 (+0.04)

KemPharm Provides Updates Regarding its Board of

GlobeNewswire via COMTEX - Fri Sep 20, 05:00PM EDT
KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that, on September 18, 2019, Danny L. Thompson provided notice of his resignation (full story)
KMPH: 0.51 (+0.04)